Kalpana Merchant

Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders

Eric E. Schadt, Sean Buchanan, K. Brennand, 2014, Front. Pharmacol..

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease

K. Merchant, C. Scherzer, Y. Kuras, 2022, Cell reports. Medicine.

Proteome Profiling of Cerebrospinal Fluid Reveals Novel Biomarker Candidates for Parkinson’s Disease

C. Scherzer, Y. Kuras, Ozge Karayel, 2021, bioRxiv.

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients

D. Krainc, M. Schwake, Daniel Ysselstein, 2019, Nature Communications.

Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons

J. Isaac, E. Sher, J. Dage, 2014, Psychopharmacology.

Finding useful biomarkers for Parkinson’s disease

A. Singleton, D. Vaillancourt, D. German, 2018, Science Translational Medicine.

Urinary proteome profiling for stratifying patients with familial Parkinson’s disease

Maximilian T. Strauss, M. Mann, K. Merchant, 2020, bioRxiv.